Report of termination of the clinical trial in the Czech Republic TUD-2DAUNO-058

Warning

This publication doesn't include Faculty of Sports Studies. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Authors	DEMLOVÁ Regina GRODOVÁ Karolína
Year of publication	2020
MU Faculty or unit	Faculty of Medicine
web	https://www.sukl.cz/modules/evaluation/detail.php?id=41660
Attached files	DaunoDouble_Informace_o_ukonceni_KH.pdf
Description	EudraCT 2013-003191-12 Randomized comparison between two dose levels of daunorubicin and between one versus two cycles of induction therapy for adult patients with acute myeloid leukemia over 60 years. Clinical Trial Termination Information provides a comprehensive overview of clinical trial (KH) information. It describes the course of KH, including a brief description, lists KH centers and their principal investigators, and provides information on KH subjects (number of patients enrolled, number of patients who completed the study, and number of patients who did not complete it). It also contains safety information and monitored efficacy parameters, measures taken during KH, and information on audits performed.
Related projects:	Český národní uzel Evropské sítě infrastruktur klinického výzkumu (CZECRIN)